Chromocure Stock Fundamentals

ChromoCure fundamentals help investors to digest information that contributes to ChromoCure's financial success or failures. It also enables traders to predict the movement of ChromoCure Stock. The fundamental analysis module provides a way to measure ChromoCure's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to ChromoCure stock.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

ChromoCure Company Current Valuation Analysis

ChromoCure's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.

Enterprise Value

 = 

Market Cap + Debt

-

Cash

More About Current Valuation | All Equity Analysis

Current ChromoCure Current Valuation

    
  850.71 K  
Most of ChromoCure's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, ChromoCure is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Competition
In accordance with the recently published financial statements, ChromoCure has a Current Valuation of 850.71 K. This is much higher than that of the sector and significantly higher than that of the Current Valuation industry. The current valuation for all United States stocks is notably lower than that of the firm.

ChromoCure Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining ChromoCure's current stock value. Our valuation model uses many indicators to compare ChromoCure value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across ChromoCure competition to find correlations between indicators driving ChromoCure's intrinsic value. More Info.
ChromoCure is rated fifth overall in return on asset category among its peers. It is rated below average in current valuation category among its peers . Comparative valuation analysis is a catch-all technique that is used if you cannot value ChromoCure by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

ChromoCure Current Valuation Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses ChromoCure's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of ChromoCure could also be used in its relative valuation, which is a method of valuing ChromoCure by comparing valuation metrics of similar companies.
ChromoCure is currently under evaluation in current valuation category among its peers.

ChromoCure Fundamentals

About ChromoCure Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze ChromoCure's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of ChromoCure using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of ChromoCure based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
ChromoCure, Inc. develops and provides proprietary cancer detection systems. ChromoCure, Inc. was incorporated in 2001 and is based in Reno, Nevada. Chromocure is traded on OTC Exchange in the United States.

Pair Trading with ChromoCure

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if ChromoCure position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ChromoCure will appreciate offsetting losses from the drop in the long position's value.

Moving against ChromoCure Stock

  0.46TCHH Trustcash HoldingsPairCorr
  0.4META Meta Platforms Aggressive PushPairCorr
  0.33TLK Telkom Indonesia TbkPairCorr
  0.31AAPL Apple IncPairCorr
The ability to find closely correlated positions to ChromoCure could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace ChromoCure when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back ChromoCure - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling ChromoCure to buy it.
The correlation of ChromoCure is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as ChromoCure moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if ChromoCure moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for ChromoCure can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment.
You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.

Other Consideration for investing in ChromoCure Stock

If you are still planning to invest in ChromoCure check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the ChromoCure's history and understand the potential risks before investing.
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities